Mark Denison

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
July 14, 2020

VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.

By Leigh MacMillan
July 9, 2020

New study supports remdesivir as COVID-19 treatment

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.

By Bill Snyder
Attendees take part in last week’s online Medical Scientist Training Program seminar.
April 16, 2020

Medical Scientist Training Program adapts to COVID-19 challenges

The Medical Scientist Training Program has been intentional in approaching the challenges presented by COVID-19.

By Leigh MacMillan
April 6, 2020

VUMC team aids development of potential antiviral drug for COVID-19

Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.

By Bill Snyder
July 18, 2019

Denison named director of Pediatric Infectious Diseases

Mark Denison, MD, has been named director of the Division of Pediatric Infectious Diseases in the Vanderbilt Department of Pediatrics.

By Christina Echegaray
June 29, 2017

Team investigates antiviral that inhibits SARS, MERS

A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.

By Leigh MacMillan
May 12, 2016

Medical societies honor four VUMC physicians

Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
By Bill Snyder
February 18, 2016

Pediatrics awarded physician-scientist training support

The National Institutes of Health (NIH) has awarded Vanderbilt’s Department of Pediatrics a K12 training grant to support early career faculty to become physician-scientists, the first time the department has received such an award.
By Matt Batcheldor
February 24, 2015

Contributors to coronavirus ‘fitness’

Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.
By Leigh MacMillan
September 12, 2013

‘Proofreader’ key to coronavirus growth

A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.
By Leigh MacMillan
November 12, 2012

UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses

Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.
By VUMC News and Communications
September 28, 2011

New group of faculty endowed chairs celebrated

Ten of Vanderbilt’s new endowed chairs were praised as leaders in their fields and on campus during a Sept. 26 ceremony at the Student Life Center.
By VUMC News and Communications